These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 23480806)

  • 21. The Challenge of Developing New Therapies for Childhood Cancers.
    Balis FM
    Oncologist; 1997; 2(1):I-II. PubMed ID: 10388032
    [TBL] [Abstract][Full Text] [Related]  

  • 22. On the Way to New Horizons: Telemedicine in Oncology.
    Schlag PM
    Oncologist; 1997; 2(2):III-IV. PubMed ID: 10388041
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene-expression assays and personalized cancer care: tissue-of-origin test for cancer of unknown primary origin.
    Takei H; Monzon FA
    Per Med; 2011 Jul; 8(4):429-436. PubMed ID: 29783334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How has the impact of 'care pathway technologies' on service integration in stroke care been measured and what is the strength of the evidence to support their effectiveness in this respect?
    Allen D; Rixson L
    Int J Evid Based Healthc; 2008 Mar; 6(1):78-110. PubMed ID: 21631815
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cancer of unknown primary site: evolving understanding and management of patients.
    Greco FA
    Clin Adv Hematol Oncol; 2012 Aug; 10(8):518-24. PubMed ID: 23073050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular profiling to optimize treatment in non-small cell lung cancer: a review of potential molecular targets for radiation therapy by the translational research program of the radiation therapy oncology group.
    Ausborn NL; Le QT; Bradley JD; Choy H; Dicker AP; Saha D; Simko J; Story MD; Torossian A; Lu B
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):e453-64. PubMed ID: 22520478
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor progression is accompanied by significant changes in the levels of expression of polyamine metabolism regulatory genes and clusterin (sulfated glycoprotein 2) in human prostate cancer specimens.
    Bettuzzi S; Davalli P; Astancolle S; Carani C; Madeo B; Tampieri A; Corti A
    Cancer Res; 2000 Jan; 60(1):28-34. PubMed ID: 10646846
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential diagnosis of renal tumors with clear cytoplasm: clinical relevance of renal tumor subclassification in the era of targeted therapies and personalized medicine.
    Goyal R; Gersbach E; Yang XJ; Rohan SM
    Arch Pathol Lab Med; 2013 Apr; 137(4):467-80. PubMed ID: 23544936
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Classification between normal and tumor tissues based on the pair-wise gene expression ratio.
    Yap Y; Zhang X; Ling MT; Wang X; Wong YC; Danchin A
    BMC Cancer; 2004 Oct; 4():72. PubMed ID: 15469618
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Integration of molecular diagnostics with therapeutics: implications for drug discovery and patient care.
    Ross JS; Ginsburg GS
    Expert Rev Mol Diagn; 2002 Nov; 2(6):531-41. PubMed ID: 12465450
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microarrays in breast cancer research and clinical practice--the future lies ahead.
    Gruvberger-Saal SK; Cunliffe HE; Carr KM; Hedenfalk IA
    Endocr Relat Cancer; 2006 Dec; 13(4):1017-31. PubMed ID: 17158752
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene expression-driven diagnostics and pharmacogenomics in cancer.
    Wang Y
    Curr Opin Mol Ther; 2005 Jun; 7(3):246-50. PubMed ID: 15977422
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recent advances in the molecular diagnosis of diffuse large B-cell lymphoma.
    Fu K; Iqbal J; Chan WC
    Expert Rev Mol Diagn; 2005 May; 5(3):397-408. PubMed ID: 15934816
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential clinical utility of gene-expression profiling in identifying tumors of uncertain origin.
    Laouri M; Halks-Miller M; Henner WD; Nystrom JS
    Per Med; 2011 Nov; 8(6):615-622. PubMed ID: 29776206
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New Technologies for Diagnosing Pediatric Tumors Expert Opinion on Medical Diagnostics.
    Wei JS; Badgett TC; Khan J
    Expert Opin Med Diagn; 2008 Nov; 2(11):1205-1219. PubMed ID: 19554203
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changing histopathological diagnostics by genome-based tumor classification.
    Kloth M; Buettner R
    Genes (Basel); 2014 May; 5(2):444-59. PubMed ID: 24879454
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeted therapeutics-oriented tumor classification: a paradigm shift.
    Quek TP; Yan B; Yong WP; Salto-Tellez M
    Per Med; 2009 Sep; 6(5):465-468. PubMed ID: 29783303
    [No Abstract]   [Full Text] [Related]  

  • 38. Highlights from the latest findings in tumor molecular profiling.
    Xiu J; Basu G; Russell K; Millis SZ
    Future Oncol; 2014 Dec; 10(15):2413-5. PubMed ID: 25525849
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of nonsteroidal antiinflammatory drugs on platelet function and systemic hemostasis.
    Schafer AI
    J Clin Pharmacol; 1995 Mar; 35(3):209-19. PubMed ID: 7608308
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Platelet alpha-granules.
    Harrison P; Cramer EM
    Blood Rev; 1993 Mar; 7(1):52-62. PubMed ID: 8467233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.